Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

NCT02503644 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Scleroderma, Diffuse
Diffuse Cutaneous Systemic Sclerosis

Interventions

DRUG: IVA337
DRUG: Placebo

Sponsor

Inventiva Pharma